Literature DB >> 4346853

Acceleration of catecholamine biosynthesis in sympathetically innervated tissues by angiotensin-II-amide..

M C Boadle-Biber, J Hughes, R H Roth.   

Abstract

1. The effect of angiotensin-II-amide on the biosynthesis of catecholamines (CA) has been studied in a number of isolated tissues in vitro.2. Angiotensin increased the synthesis of CA from (14)C-tyrosine in guinea-pig atria and portal vein, in rat vasa deferentia and the rabbit portal vein.3. Angiotensin had no effect on synthesis of CA from (14)C-labelled DL-DOPA.4. The conditions required to demonstrate an increased synthesis were critical with respect to incubation time and angiotensin concentration. Effects were most readily apparent after incubation for 1 h with concentrations of angiotensin ranging from 10(-9) to 10(-7)M. Higher concentrations caused a significant reduction in synthesis.5. An increased release of newly synthesized CA into the incubation medium was sometimes seen in the presence of angiotensin. However, there was no correlation between increased synthesis and release of CA.6. Angiotensin was rapidly destroyed when incubated with guinea-pig or rat tissues in Krebs solution. The increase in CA synthesis was only apparent at a time when the incubation medium could have contained only a fraction of the original angiotensin activity.7. It is concluded that the effect of angiotensin is not due to increased release of noradrenaline (NA) or to inhibition of NA uptake into nerves. It is possible that angiotensin may influence the activity of tyrosine hydroxylase or its cofactors by an as yet unknown mechanism.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4346853      PMCID: PMC1666355          DOI: 10.1111/j.1476-5381.1972.tb06874.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  31 in total

1.  The action of angiotensin and bradykinin on the superior cervical ganglion of the cat.

Authors:  G P Lewis; E Reit
Journal:  J Physiol       Date:  1965-08       Impact factor: 5.182

2.  Sympathetically mediated effects of angiotensin on the dog heart in situ.

Authors:  W C Farr; G Grupp
Journal:  J Pharmacol Exp Ther       Date:  1967-06       Impact factor: 4.030

3.  Inhibition of noradrenaline uptake by angiotensin.

Authors:  D Palaic; P A Khairallah
Journal:  J Pharm Pharmacol       Date:  1967-06       Impact factor: 3.765

4.  Effect of angiotensin and phenoxybenzamine on release of norepinephrine in vessels during sympathetic nerve stimulation.

Authors:  B G Zimmerman; L Whitmore
Journal:  Int J Neuropharmacol       Date:  1967-01

5.  The release of catecholamines from the adrenal medulla by peptides.

Authors:  J Staszewska-Barczak; J R Vane
Journal:  Br J Pharmacol Chemother       Date:  1967-08

6.  On the central hypertensive effect of angiotensin II.

Authors:  W B Severs; A E Daniels; J P Buckley
Journal:  Int J Neuropharmacol       Date:  1967-05

7.  Effects of angiotensin on the superior cervical ganglion of the cat.

Authors:  J C Panisset; P Biron; A Beaulnes
Journal:  Experientia       Date:  1966-06-15

8.  Observations on the ganglion-stimulating action of angiotensin and bradykinin.

Authors:  U Trendelenburg
Journal:  J Pharmacol Exp Ther       Date:  1966-12       Impact factor: 4.030

9.  Further studies on the actions of peptides on the superior cervical ganglion and suprarenal medulla.

Authors:  G P Lewis; E Reit
Journal:  Br J Pharmacol Chemother       Date:  1966-02

10.  Centrally mediated cardiovascular effects of angiotensin II.

Authors:  H H Smookler; W B Severs; W J Kinnard; J P Buckley
Journal:  J Pharmacol Exp Ther       Date:  1966-09       Impact factor: 4.030

View more
  2 in total

Review 1.  Factors involved in the pathogenesis of hypertensive cardiovascular hypertrophy. A review.

Authors:  B Dahlöf
Journal:  Drugs       Date:  1988       Impact factor: 9.546

2.  Angiotensin II mediates the axonal trafficking of tyrosine hydroxylase and dopamine β-hydroxylase mRNAs and enhances norepinephrine synthesis in primary sympathetic neurons.

Authors:  Armaz Aschrafi; Adama Berndt; Jeffrey A Kowalak; Jenna R Gale; Anthony E Gioio; Barry B Kaplan
Journal:  J Neurochem       Date:  2019-07-31       Impact factor: 5.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.